Jeffrey D. Capello
Independent DirectorMr. Jeffrey D. Capello, also known as Jeff, is an Independent Director at Neogen Corporation since September 02, 2022. He was Interim Chief Financial Officer at Photys Therapeutics, Inc. He serves as Independent Director of Agios Pharmaceuticals, Inc. since June 2023. He was with ValueOptions of Texas, Inc. and Value Behavioral Health of Pennsylvania, Inc. He serves as the Chief Financial Officer and Chief Operating Officer at ImmuneID, Inc. He is associated as Director at Gravitas Medical Inc. since September 2022. He served as a Director of OvaScience, Inc. since March 2012. Mr. Capello served as an Executive Vice President and Chief Financial Officer of Biogen Inc. since December 2017 until August 15, 2020. He was Chief Accounting Officer at Biogen Inc. since July 11, 2018 until November 19, 2018. Mr. Capello served as the Chief Financial Officer and Executive Vice President of Beacon Health Options, Inc., a behavioral health company, with responsibility for finance, human resources, information technology, real estate and procurement from September 2016 to December 2017. From July 2015 until September 2016, Mr. Capello was the Founder and served as Chief Executive Officer of Monomoy Advisors which focuses on helping companies drive shareholder value. From July 2014 until May 2015, Mr. Capello served as the Executive Vice President and Chief Financial Officer of OrthoClinical Diagnostics, an in vitro diagnostics company that was acquired by the Carlyle Group from Johnson & Johnson, with responsibility for global finance and business development. Mr. Capello served as a Member of the Board of Sirtris Pharmaceuticals, Inc. since 2008. Mr. Capello served as Chief Financial Officer and Executive Vice President of Boston Scientific Corporation, a medical device company, from March 2010 to December 2013. At Boston Scientific, Mr. Capello was responsible for the worldwide management of Boston Scientific’s finance, information systems, business development and corporate strategy functions. Mr. Capello joined Boston Scientific in June 2008 and served as Senior Vice President and Chief Accounting Officer until March 2010. Prior to joining Boston Scientific, he was the Senior Vice President and Chief Financial Officer with responsibilities for global finance and business development at PerkinElmer, Inc., a life sciences tool company, from 2006 to 2008. Previously, he served as PerkinElmer’s Vice President of Finance, Corporate Controller, Treasurer and Chief Accounting Officer from 2001 to 2005. Prior to his tenure at PerkinElmer, Mr. Capello was a Partner at PricewaterhouseCoopers LLP, both in the United States and in the Netherlands. He is a Certified Public Accountant. He served as an Independent Director of Flex Pharma, Inc. from April 2015 to June 6, 2018. Mr. Capello holds Bachelor of Science degree in Business Administration from the University of Vermont and a Master of Business Administration Degree from Harvard Business School.
Positions
- Company NameNeogen CorporationStock CodeNEOGPositionIndependent DirectorColleagues
- MNMikhael NassifCEO, President & Director
- JCJames C. BorelIndependent Chairman
- RBR. Bryan RiggsbeeCFO & Senior Vice President
- JEJennifer Evans StaceySenior VP, Chief Legal & Compliance Officer and Board Secretary
- TATamara A. RanalliSenior VP & GM of Global Food Safety
- JMJohn MoylanVP, Corporate Controller & Chief Accounting Officer
- RDRonald D. GreenIndependent Director
- CECatherine E. WotekiIndependent Director
- JDJeffrey D. CapelloIndependent Director
- Company NameAgios Pharmaceuticals, Inc.Stock CodeAGIOPositionIndependent DirectorColleagues
- BMBrian M. GoffCEO & Director
- JAJacqualyn A. FouseChair of the Board of Directors
- CJCecilia JonesChief Financial Officer
- KVKrishnan ViswanadhanChief Strategy & Operations Officer
- JWJames William BurnsChief Legal Officer
- SGSarah GheuensChief Medical Officer and Head of Research & Development
- KIKaye I. Foster-CheekLead Independent Director
- CSCynthia SmithIndependent Director
